2-(4-Trifluorophenyl)-4-(2-hydroxyphenyl)-5H-indeno[1,2-b]-pyridin-8-ol

ID: ALA4475893

PubChem CID: 155537787

Max Phase: Preclinical

Molecular Formula: C25H16F3NO2

Molecular Weight: 419.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Oc1ccc2c(c1)-c1nc(-c3ccc(C(F)(F)F)cc3)cc(-c3ccccc3O)c1C2

Standard InChI:  InChI=1S/C25H16F3NO2/c26-25(27,28)16-8-5-14(6-9-16)22-13-20(18-3-1-2-4-23(18)31)21-11-15-7-10-17(30)12-19(15)24(21)29-22/h1-10,12-13,30-31H,11H2

Standard InChI Key:  KLGOXMONWWADHR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   23.9571  -19.3525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9560  -20.1721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6640  -20.5810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.6623  -18.9437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6570  -18.1293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3651  -17.7192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3630  -16.9028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6536  -16.4955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9447  -16.9106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9503  -17.7257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2499  -20.5804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5422  -20.1695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8346  -20.5769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8336  -21.3949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5459  -21.8039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2506  -21.3942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3709  -19.3489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3757  -20.1675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1480  -19.0915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6331  -19.7509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1527  -20.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4863  -21.1584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3001  -21.2423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7791  -20.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4428  -19.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6354  -21.9875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.1261  -21.8039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4181  -21.3957    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.1265  -22.6211    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.4133  -22.2045    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.0736  -18.1264    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3 18  2  0
 17  4  2  0
  4  1  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  2 11  1  0
 17 18  1  0
 18 21  1  0
 20 19  1  0
 19 17  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 14 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
  6 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475893

    ---

Associated Targets(Human)

HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.40Molecular Weight (Monoisotopic): 419.1133AlogP: 6.42#Rotatable Bonds: 2
Polar Surface Area: 53.35Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.27CX Basic pKa: 3.31CX LogP: 6.86CX LogD: 6.85
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.35Np Likeness Score: -0.18

References

1. Kadayat TM, Park S, Shrestha A, Jo H, Hwang SY, Katila P, Shrestha R, Nepal MR, Noh K, Kim SK, Koh WS, Kim KS, Jeon YH, Jeong TC, Kwon Y, Lee ES..  (2019)  Discovery and Biological Evaluations of Halogenated 2,4-Diphenyl Indeno[1,2-b]pyridinol Derivatives as Potent Topoisomerase IIα-Targeted Chemotherapeutic Agents for Breast Cancer.,  62  (17): [PMID:31398033] [10.1021/acs.jmedchem.9b00970]

Source